F2RL2
Basic information
Region (hg38): 5:76615482-76623413
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the F2RL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 22 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 0 | 0 |
Variants in F2RL2
This is a list of pathogenic ClinVar variants found in the F2RL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-76617647-C-T | not specified | Uncertain significance (Jan 18, 2022) | ||
5-76617707-C-T | not specified | Uncertain significance (May 26, 2024) | ||
5-76617736-T-C | not specified | Uncertain significance (Nov 13, 2024) | ||
5-76617763-G-A | not specified | Uncertain significance (May 24, 2023) | ||
5-76617803-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
5-76617827-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
5-76617830-C-A | not specified | Uncertain significance (May 03, 2023) | ||
5-76617868-T-C | not specified | Uncertain significance (Feb 27, 2023) | ||
5-76617896-A-G | not specified | Uncertain significance (Oct 01, 2024) | ||
5-76617923-A-C | not specified | Uncertain significance (Aug 02, 2021) | ||
5-76617935-A-G | not specified | Uncertain significance (Aug 27, 2024) | ||
5-76618021-A-G | not specified | Uncertain significance (Apr 19, 2024) | ||
5-76618037-A-G | not specified | Uncertain significance (May 31, 2023) | ||
5-76618129-A-G | not specified | Uncertain significance (Jan 04, 2024) | ||
5-76618135-C-A | not specified | Uncertain significance (Oct 11, 2024) | ||
5-76618153-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
5-76618204-G-C | not specified | Uncertain significance (Feb 27, 2023) | ||
5-76618204-G-T | not specified | Uncertain significance (Jul 06, 2021) | ||
5-76618304-G-C | not specified | Uncertain significance (Jan 23, 2023) | ||
5-76618306-T-C | not specified | Uncertain significance (Sep 20, 2024) | ||
5-76618328-A-G | not specified | Uncertain significance (Dec 21, 2022) | ||
5-76618378-G-A | not specified | Uncertain significance (Oct 16, 2024) | ||
5-76618477-T-C | not specified | Uncertain significance (Oct 05, 2021) | ||
5-76618485-A-C | not specified | Uncertain significance (Jan 29, 2024) | ||
5-76618502-T-C | not specified | Uncertain significance (Sep 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
F2RL2 | protein_coding | protein_coding | ENST00000296641 | 2 | 7953 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000175 | 0.458 | 125708 | 0 | 39 | 125747 | 0.000155 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.410 | 185 | 201 | 0.919 | 0.0000100 | 2446 |
Missense in Polyphen | 47 | 56.123 | 0.83744 | 728 | ||
Synonymous | 0.110 | 77 | 78.2 | 0.984 | 0.00000389 | 763 |
Loss of Function | 0.485 | 8 | 9.62 | 0.831 | 4.07e-7 | 135 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00101 | 0.00100 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000115 | 0.000114 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for activated thrombin coupled to G proteins that stimulate phosphoinositide hydrolysis. {ECO:0000269|PubMed:10079109}.;
- Pathway
- Complement and coagulation cascades - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Regulation of Microtubule Cytoskeleton;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);Thrombin signalling through proteinase activated receptors (PARs);GPCR ligand binding;Platelet activation, signaling and aggregation;ErbB1 downstream signaling;Hemostasis;G alpha (q) signalling events;GPCR downstream signalling;Insulin Pathway;PAR4-mediated thrombin signaling events;PAR1-mediated thrombin signaling events;CDC42 signaling events;Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met);Nephrin/Neph1 signaling in the kidney podocyte;RhoA signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.560
- rvis_EVS
- 0.77
- rvis_percentile_EVS
- 87.06
Haploinsufficiency Scores
- pHI
- 0.134
- hipred
- Y
- hipred_score
- 0.565
- ghis
- 0.401
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.324
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- F2rl2
- Phenotype
- homeostasis/metabolism phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;blood coagulation;response to wounding;platelet activation;positive regulation of Rho protein signal transduction;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;thrombin-activated receptor signaling pathway
- Cellular component
- extracellular region;plasma membrane;integral component of plasma membrane;apical plasma membrane;protein-containing complex
- Molecular function
- phosphatidylinositol phospholipase C activity;G protein-coupled receptor activity;protein binding;thrombin-activated receptor activity